1. The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta-analysis

   • Jiehua Wei
   • Fan Xia
   • Xuemei Yan

   Review 12 November 2022 Pages: 1 - 11

   

2. Correction to: The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta‑analysis

   • Jiehua Wei
   • Fan Xia
   • Xuemei Yan

   Correction 22 November 2022 Pages: 13 - 13

3. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data

   • Mahsa Ghodousi
   • Hedyieh Karbasforooshan
   • Sepideh Elyasi

   Review 01 December 2022 Pages: 15 - 38

   

4. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose–response meta-analysis

   • Shaodi Ma
   • Guangbo Qu
   • Yehuan Sun

   Research 05 November 2022 Pages: 39 - 61

   

5. Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis

   • Xiaowen Hou
   • Kaiwen Cen
   • Xu Feng

   Research 07 November 2022 Pages: 63 - 70

   

6. Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia

   • Issa Issa
   • Jakob Skov
   • Buster Mannheimer

   Research Open access 15 November 2022 Pages: 71 - 77

   

7. Comparative polymyxin B pharmacokinetics in critically ill patients with renal insufficiency and in continuous veno-venous hemodialysis

   • Yury A. Surovoy
   • Maksim A. Burkin
   • Sergei V. Tsarenko

   Research 15 November 2022 Pages: 79 - 87

   

8. Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate

   • Yoshiko Takahashi
   • Shintaro Narita
   • Tomonori Habuchi

   Research 15 November 2022 Pages: 89 - 98

   

9. Impact of suspected adverse drug reactions on mortality and length of hospital stay in the hospitalised patients: a meta-analysis

   • Tejas K. Patel
   • Parvati B. Patel
   • Surekha Kishore

   Research 18 November 2022 Pages: 99 - 116

   

10. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service—a cross-sectional study of patients in a Canadian Health Region

    • Kwadwo Osei Bonsu
    • Stephanie W. Young
    • Rufaro S. Chitsike

    Research 18 November 2022 Pages: 117 - 125

11. Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation

    • Junichi Nakagawa
    • Takahiko Kinjo
    • Takenori Niioka

    Research 18 November 2022 Pages: 127 - 135

    

12. Utility of in silico prediction of target suppression for antibodies against soluble targets: static versus dynamic models

    • Youssef Hijazi

    Research 22 November 2022 Pages: 137 - 147

    

13. A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure

    • Ru Liao
    • Yalin Dong
    • Haiyan Dong

    Research 25 November 2022 Pages: 149 - 157

    

14. Risk of cardiovascular events according to the tricyclic antidepressant dosage in patients with chronic pain: a retrospective cohort study

    • Hyunji Koo
    • Seung Hun You
    • Sun-Young Jung

    Research 29 November 2022 Pages: 159 - 171

    

15. Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010–2019

    • Jacqueline M. Cohen
    • Chaitra Srinivas
    • Øystein Karlstad

    Research Open access 29 November 2022 Pages: 173 - 180

    

16. Training clinical trial teams of the future: open online teaching programs

    • Jitka Rychlickova
    • Viktoria Nagy
    • Joana Batuca

    Correspondence 23 November 2022 Pages: 181 - 182